This week, Dr. Devi Nair, electrophysiologist at St. Bernards Medical Center, became the first physician in the world to use the TactiCath Quartz ablation catheter, which helps treat patients with atrial fibrillation.
Atrial fibrillation (AFib) is a quivering or irregular heartbeat that can lead to blood clots, stroke, heart failure and other complications.
“The new TactiCath contact ablation catheter unites fiber optics, flexibility and 3D mapping,” said Dr. Nair. “The catheter emphasizes accuracy and precision through dual impedance and magnetic technologies designed to precisely model the heart to determine where to apply optimal contact force. I am honored to be part of the global trial and to be the first to use the catheter, and I am proud of my amazing EP team that is as excited as me in delivering cutting-edge technology.”
The TactiCath is part of a global clinical trial to help patients with drug refractory persistent atrial fibrillation.
“Atrial fibrillation is a very common health issue we see here in Northeast Arkansas, so we are excited to bring this new, cutting-edge technique to our patients,” said Connie Hill, vice president of cancer and heart services at St. Bernards. “I am incredibly proud of Dr. Nair and the entire electrophysiology team, who continue to take our program to the next level.”